BioSpace News Archive

Palliare Completes $8m Series A Funding Round

Palliare, an emerging company with the vision to create a safer operating room, announced the closing of an oversubscribed $8 million Series A funding round.

June 28, 2021
·
3 min read
Medical Coatings Market: Demand for hydrophilic coatings is projected to be high in the coming years

The increase in disposable income in developing regions, a growing percentage of the senior population, and are all contributing towards the development of the global medical coatings market.

June 28, 2021
·
6 min read
Increasing Number of Organ Transplantation Conducted Globally Driving Organ Care Market: Fact.MR

Fact.MR, Dubai: The global organ care market is expected to witness a steady growth during the forecast period 2021 to 2031.

June 28, 2021
·
4 min read
Drug Development

MaaT Pharma Announces DSMB Approval to Proceed to Cohort 4 out of 5 in Phase 1b CIMON Trial Testing Capsule Formulation of Microbiome Ecosystem Therapy

MaaT Pharma, a clinical-stage biotechnology company focused on developing Microbiome Ecosystem Therapies in oncology, announced that the Data Safety and Monitoring Board recommended to proceed to the fourth cohort of the dose-finding Phase 1b CIMON clinical trial, without modifications.

June 28, 2021
·
3 min read
Orthopedic Navigation Systems Market: Increasing usage of Navigation Software by Physicians and Surgeons to Drive the Market

Computer-assisted navigation systems or orthopedic navigation systems incorporate intra-operative execution and pre-operative planning information by demonstrating three-dimensional computer images in relative patient anatomy that is image-guided surgery systems.

June 28, 2021
·
5 min read
Healthcare Distribution Market: Increase the specialized medicines distribution to drive the market

The global healthcare distribution market includes storing and moving pharmaceutical goods from production plants to wholesalers, hospitals or patients.

June 28, 2021
·
5 min read
Business

Ribon Therapeutics Appoints Paul Brannelly as Chief Financial Officer

Ribon Therapeutics, a clinical stage biotechnology company developing therapeutics targeting stress support pathways, announced the appointment of Paul Brannelly as Chief Financial Officer.

June 28, 2021
·
3 min read
Drug Development

Precision BioSciences and SpringWorks Therapeutics Dose First Patient in Expanded Phase 1/2a Clinical Trial Evaluating PBCAR269A with Nirogacestat in Patients with Relapsed/Refractory Multiple Myeloma

Precision BioSciences, Inc. and SpringWorks Therapeutics, Inc. announced that the first patient has been dosed in the combination arm of Precision’s Phase 1/2a trial evaluating PBCAR269A.

June 28, 2021
·
14 min read
Drug Development

Atsena Therapeutics Receives Orphan Drug Designation from the FDA for Novel Gene Therapy to Treat Genetic Eye Disease LCA1Phase I/II clinical trial is ongoing in patients with Leber congenital amaurosis caused by biallelic mutations in GUCY2D

Atsena Therapeutics today announced that the U.S. Food and Drug Administration (FDA) has granted orphan drug designation for its investigational gene therapy product for the treatment of GUCY2D -associated Leber congenital amaurosis (LCA1), a genetic eye disease that affects the retina.

June 28, 2021
·
2 min read
Business

Psyence Group Announces Appointment of New Chief Executive OfficerCurrent CEO to assume role of Executive Chairman

Psyence Group Inc. is pleased to announce that it has appointed Dr. Neil Maresky as Chief Executive Officer.

June 28, 2021
·
6 min read